COMPONENT E-S IMPLANTS WITH TYLAN DIN 02245743
Health Canada record
| Active ingredient(s) | TYLOSIN TARTRATE 29 MG; PROGESTERONE 200 MG; ESTRADIOL BENZOATE 20 MG |
|---|---|
| Dosage form | Implant |
| Route | Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 25-Sep-2002 |
| Current status date | 18-Oct-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TYLOSIN TARTRATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00079235 | TYLOCINE PWS 100GM/TYLOCINE PWS 23KG | CORVEL, DIVISION OF ELI LILLY CANADA INC. | Powder For Solution | TYLOSIN TARTRATE 920 MCG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22864 | 2019-11-07 | Supplement to a New Drug Submission (SNDS) | Addition of a new manufacturing site ¿ Tylosin Tartrate |
| 20475 | 2018-02-14 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 20245 | 2018-01-08 | Supplement to a New Drug Submission (SNDS) | CHANGE TO A PRESCRIPTIOM STATUS. lABELLING UPDATES |
| 14129 | 2013-02-18 | New Drug Submission (NDS) | Transfer of DIN ownerhsip |
| 6098 | 2002-05-21 | New Drug Submission (NDS) |
International API supply for TYLOSIN TARTRATE
0 active FDA Drug Master Files.
Request a quote for COMPONENT E-S IMPLANTS WITH TYLAN